The Bulletin
Times Advertising


.

Shenzhen and Hong Kong Join Hands to Promote the Development of the Hetao Shenzhen-Hong Kong Science & Technology Innovation Co-operation Zone

  • Written by The Bulletin

"Driving the Globalization of Clinical Trials in the Guangdong-Hong Kong-Macao Greater Bay Area, Implementing the First Key Cross-Border Multi-Center Clinical Trial Project"

HONG KONG SAR - Media OutReach Newswire - 30 July 2025 - The Greater Bay Area International Clinical Trial Institute of Hong Kong ("GBAICTI"), the Greater Bay Area International Clinical Trials Center of Shenzhen ("BAY TRIAL"), Immuno Cure BioTech ("Immuno Cure") in Hong Kong are pleased to jointly announce today the signing of a tripartite Memorandum of Understanding ("MOU") in Shenzhen on July 29, 2025.

Read more: Shenzhen and Hong Kong Join Hands to Promote the Development of the Hetao Shenzhen-Hong Kong...